| [1] |
Paget S.The distribution of secondary growths in cancer of the breast.1889[J].Cancer Metastasis Rev,1989,8(2):98-101.
|
| [2] |
Katheder NS,Khezri R,O′Farrell F,et al.Microenvironmental autophagy promotes tumour growth[J].Nature,2017,541(7637):417-420.
|
| [3] |
Ishii G,Ochiai A,Neri S.Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment[J].Adv Drug Deliv Rev,2016,99(Pt B):186-196.
|
| [4] |
Komohara Y,Takeya M.CAFs and TAMs:maestros of the tumour microenvironment[J].J Pathol,2017,241(3):313-315.
|
| [5] |
Boju P,Quan L,Zheyu N,et al.Cancer-associated fibroblasts in pancreatic adenocarcinoma[J].Future Oncol,2015,11(18):2603-2610.
|
| [6] |
Kumar MM,Davuluri S,Poojar S,et al.Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts:a transcriptomic study[J].Tumour Biol,2016,37(4):4409-4420.
|
| [7] |
Harati K,Daigeler A,Hirsch T,et al.Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells[J].Int J Mol Biol Med,2016,37(6):1535-1541.
|
| [8] |
Fullár A, Dudás J, Oláh L, et al. Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression[J].BMC Cancer,2015,15(1):256.
|
| [9] |
Mahale J,Smagurauskaite G,Brown K,et al.The role of stromal fibroblasts in lung carcinogenesis:a target for chemoprevention[J].Int J Cancer,2015,138(1):30-44.
|
| [10] |
Arrigoni C,Luca P,Gilardi M,et al.Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases[J].Mol Cancer,2014,13(1):1-6.
|
| [11] |
Ma JC,Sun XW,Su H,et al.Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer[J].World J Gastroenterol,2017,23(28):5167-5178.
|
| [12] |
Izumi D,Ishimoto T,Miyake K,et al.CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer[J].Int J Cancer,2016,138(5):1207-1219.
|
| [13] |
Tan X,Fu Y,Chen L,et al.miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer[J].Oncotarget,2016,7(1):293-307.
|
| [14] |
Yang J,Lu Y,Lin YY,et al.Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma[J].Cancer Lett,2016,383(1):18-27.
|
| [15] |
Owusu BY,Galemmo R,Janetka J,et al.Hepatocyte growth factor,a key tumor-promoting factor in the tumor microenvironment[J].Cancers,2017,9(4):1-16.
|
| [16] |
Saito S,Morishima K,Ui T,et al.The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma[J].BMC Cancer,2015,15:82.
|
| [17] |
Richards CD.Innate immune cytokines,fibroblast phenotypes,and regulation of extracellular matrix in lung[J].J Interferon Cytokine Res,2017,37(2):52-61.
|
| [18] |
Chen B,Dai W,Mei D,et al.Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system[J].J Control Release,2016,241(1):68-80.
|
| [19] |
Koczorowska MM,Tholen S,Bucher F,et al.Fibroblast activation protein-α,a stromal cell surface protease,shapes key features of cancer associated fibroblasts through proteome and degradome alterations[J].Mol Oncol,2016,10(1):40-58.
|
| [20] |
Liao Y,Xing S,Xu B,et al.Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma[J].Oncotarget,2017,8(18):30050-30062.
|
| [21] |
Huang S,Fang R,Xu J,et al.Evaluation of the tumor targeting of a FAP-based doxorubicin prodrug[J].J Drug Target,2011,19(7):487-496.
|
| [22] |
Brennen WN, Rosen DM, Wang H, et al. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug[J].J Natl Cancer Inst,2012,104(17):1320-1334.
|
| [23] |
Lebeau AM,Denmeade SR.Protease-activated pore-forming peptides for the treatment and imaging of prostate cancer[J].Mol Cancer Ther,2015,14(3):659-668.
|
| [24] |
Ke MR,Chen SF,Peng XH,et al.A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy[J].Eur J Med Chem,2017,127(1):200-209.
|
| [25] |
Miao L,Wang Y,Xiong Y,et al.Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin[J].J Control Release,2015,217(1):27-41.
|
| [26] |
Sanchez-Ruiz J,Quintela-Fandino M.Targeting the tumor stroma in breast cancer[J].Curr Breast Cancer Rep,2015,7(1):71-79.
|
| [27] |
Ernsting MJ,Hoang B,Lohse I,et al.Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle[J].J Control Release,2015,206(1):122-130
|
| [28] |
Guo S,Lin CM,Xu Z,et al.Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation[J].ACS Nano,2014,8(5):4996-5009.
|
| [29] |
De Vlieghere E,Verset L,Demetter P,et al.Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics[J].Virchows Arch,2015,467(4):367-382.
|
| [30] |
Miao L,Liu Q,Lin CM,et al.Targeting tumor-associated fibroblasts for therapeutic delivery in desmoplastic tumors[J].Cancer Res,2017,77(3):719-731.
|
| [31] |
Chen B,Dai W,He B,et al.Current multistage drug delivery systems based on the tumor microenvironment[J].Theranostics,2017,7(3):538-558.
|
| [32] |
Chen B,Dai W,Mei D,et al.Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system[J].J Control Release,2016,241(1):68-80.
|
| [33] |
Chen B,Wang Z,Sun J,et al.A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts[J].Nanomedicine,2015,12(1):131-141.
|
| [34] |
Chen B,Dai W,Mei D,et al.Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system[J].J Control Release,2016,241(1):68-80.
|
| [35] |
Fang J, Xiao L, Joo K, et al. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice[J].Int J Cancer,2016,138(4):1013-1023.
|
| [36] |
Ji T,Zhao Y,Ding Y,et al.Transformable peptide nanocarriers for expeditious drug release and effective cancer therapy via cancer-associated fibroblast activation[J].Angew Chem Int Ed Engl,2016,55(3):1050-1055.
|
| [37] |
Ji T,Ding Y,Zhao Y,et al.Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery[J].Adv Mater,2015,27(11):1865-1873.
|
下载:
